NCT03849183

Brief Summary

The primary objective of the study is to evaluate the vasodilative effect of subcutaneous nitroglycerin during ultrasound-guided radial artery cannulation in pediatric patients. The hypothesis of this study is that the subcutaneous nitroglycerin will increase the radial artery size and improve the first-attempt success rate of radial artery cannulation. This is a single-center, double-blind, randomized, placebo-controlled study comparing the effect of subcutaneous nitroglycerin and saline on radial artery cannulation in pediatric patients undergoing general anesthesia. Prior to the procedure, each patient will be randomized into either the control arm, saline, or study arm, nitroglycerin.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
116

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Mar 2019

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 18, 2019

Completed
3 days until next milestone

First Posted

Study publicly available on registry

February 21, 2019

Completed
27 days until next milestone

Study Start

First participant enrolled

March 20, 2019

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 22, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 22, 2019

Completed
Last Updated

November 6, 2019

Status Verified

November 1, 2019

Enrollment Period

4 months

First QC Date

February 18, 2019

Last Update Submit

November 4, 2019

Conditions

Keywords

Radial ArteryVascular Catheters

Outcome Measures

Primary Outcomes (1)

  • First attempt success rate

    Success at the first skin puncture

    During radial artery cannulation (up to 1 hour)

Secondary Outcomes (7)

  • Size of radial artery

    Before and after subcutaneous injection of drugs (up to 1 hour)

  • depth of radial artery

    Before and after subcutaneous injection of drugs (up to 1 hour)

  • Overall attempt

    During radial artery cannulation (up to 1 hour)

  • Overall Procedure time

    During radial artery cannulation (up to 1 hour)

  • Overall success rate

    During radial artery cannulation (up to 1 hour)

  • +2 more secondary outcomes

Study Arms (2)

Nitroglycerin

EXPERIMENTAL

Nitroglycerin 5mcg/kg (0.5cc) is subcutaneously injected before radial artery cannulation.

Drug: Nitroglycerin

Control

ACTIVE COMPARATOR

Normal saline (0.5cc) is subcutaneously injected before radial artery cannulation.

Drug: Normal saline

Interventions

Subcutaneous nitroglycerin injection to increase the first attempt success rate of radial artery cannulation in pediatric patients

Also known as: Subcutaneous Nitroglycerin
Nitroglycerin

Subcutaneous normal saline injection to increase the first attempt success rate of radial artery cannulation in pediatric patients

Also known as: Subcutaneous Normal saline
Control

Eligibility Criteria

AgeUp to 2 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • General anesthesia
  • Arterial cannulation for hemodynamic monitoring, multiple blood sample

You may not qualify if:

  • Hypersensitivity or contraindication to nitroglycerine
  • Unstable vital sign, significant arrhythmia or hypotension, Shock
  • High risk of peripheral ischemia
  • Skin disease, infection, hematoma, recent cannulation at radial artery.
  • Increased intracranial pressure, Intracranial hemorrhage
  • Glaucoma
  • Recent use of PDE5 inhibitors (\<24 hours after sildenafil or vardenafil; \<48 hours after tadalafil)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Jin-Tae Kim

Seoul, South Korea

Location

Related Publications (6)

  • Chong AY, Lo T, George S, Ratib K, Mamas M, Nolan J. The effect of pre-procedure sublingual nitroglycerin on radial artery diameter and Allen's test outcome - Relevance to transradial catheterization. Cardiovasc Revasc Med. 2018 Mar;19(2):163-167. doi: 10.1016/j.carrev.2017.07.016. Epub 2017 Jul 29.

    PMID: 28923695BACKGROUND
  • Chen Y, Ke Z, Xiao J, Lin M, Huang X, Yan C, Ye S, Tan X. Subcutaneous Injection of Nitroglycerin at the Radial Artery Puncture Site Reduces the Risk of Early Radial Artery Occlusion After Transradial Coronary Catheterization: A Randomized, Placebo-Controlled Clinical Trial. Circ Cardiovasc Interv. 2018 Jul;11(7):e006571. doi: 10.1161/CIRCINTERVENTIONS.118.006571.

    PMID: 30002088BACKGROUND
  • Kim EH, Lee JH, Song IK, Kim JT, Lee WJ, Kim HS. Posterior Tibial Artery as an Alternative to the Radial Artery for Arterial Cannulation Site in Small Children: A Randomized Controlled Study. Anesthesiology. 2017 Sep;127(3):423-431. doi: 10.1097/ALN.0000000000001774.

    PMID: 28682811BACKGROUND
  • Ezhumalai B, Satheesh S, Jayaraman B. Effects of subcutaneously infiltrated nitroglycerin on diameter, palpability, ease-of-puncture and pre-cannulation spasm of radial artery during transradial coronary angiography. Indian Heart J. 2014 Nov-Dec;66(6):593-7. doi: 10.1016/j.ihj.2014.05.023. Epub 2014 Jun 7.

    PMID: 25634390BACKGROUND
  • Beyer AT, Ng R, Singh A, Zimmet J, Shunk K, Yeghiazarians Y, Ports TA, Boyle AJ. Topical nitroglycerin and lidocaine to dilate the radial artery prior to transradial cardiac catheterization: a randomized, placebo-controlled, double-blind clinical trial: the PRE-DILATE Study. Int J Cardiol. 2013 Oct 3;168(3):2575-8. doi: 10.1016/j.ijcard.2013.03.048. Epub 2013 Apr 10.

    PMID: 23582415BACKGROUND
  • Majure DT, Hallaux M, Yeghiazarians Y, Boyle AJ. Topical nitroglycerin and lidocaine locally vasodilate the radial artery without affecting systemic blood pressure: a dose-finding phase I study. J Crit Care. 2012 Oct;27(5):532.e9-13. doi: 10.1016/j.jcrc.2012.04.019. Epub 2012 Jun 12.

    PMID: 22699036BACKGROUND

MeSH Terms

Interventions

NitroglycerinSaline Solution

Intervention Hierarchy (Ancestors)

Nitro CompoundsOrganic ChemicalsCrystalloid SolutionsIsotonic SolutionsSolutionsPharmaceutical Preparations

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

February 18, 2019

First Posted

February 21, 2019

Study Start

March 20, 2019

Primary Completion

July 22, 2019

Study Completion

July 22, 2019

Last Updated

November 6, 2019

Record last verified: 2019-11

Locations